Conférence
Notice
Langue :
Anglais
Crédits
Université de Bordeaux - Service Audiovisuel et Multimédia (Production), Université de Bordeaux - Service Audiovisuel et Multimédia (Publication), Université de Bordeaux - Service Audiovisuel et Multimédia (Réalisation), Pierre Soubeyran (Intervention)
Conditions d'utilisation
Creative Commons (BY NC)
DOI : 10.60527/tg3f-5322
Citer cette ressource :
Pierre Soubeyran. Univ Bordeaux. (2014, 7 novembre). BRIO's facts and figures, structuration projects : Axe Cancer, translational research centerUpdate the implementation of BRIO , in BRIO SIRIC scientific day 2. [Vidéo]. Canal-U. https://doi.org/10.60527/tg3f-5322. (Consultée le 7 juin 2025)
Logo Université de Bordeaux
Université de Bordeaux - SAM
S'abonner
Contacter

BRIO's facts and figures, structuration projects : Axe Cancer, translational research centerUpdate the implementation of BRIO

Réalisation : 7 novembre 2014 - Mise en ligne : 18 décembre 2014
  • document 1 document 2 document 3
  • niveau 1 niveau 2 niveau 3
Descriptif

Update the implementation of BRIO


Brio organisation is now fully up and running, and more than 100research projects are currently active into the 6 integrated researchprogrammes. In addition, major progresses were achieved at the level of the 7strategic axes defined to structure and support cancer research in Bordeaux.The bioinformatics axis saw the recruitment of 4 bioinformaticians (2 funded byBRIO) and the creation of a transversal bioinformatics axis at the University.For the in-vivo research axis, a project to develop a translational research centeris currently being developed (see Bordeaux Cancer section). A new Insermcandidate unit “Cancer Epidemiology and Environmental Exposures” is beingproposed to consolidate the health outcome axis. Databases have been the topicof the first inter-SIRIC collaboration and 4 working groups have been defined.The personalised medicine axis is being supported by BRIO-funded techniciansand will be further consolidated with a post-doctoral fellow. A new HHS groupwas formed to support HHS projects in cancer and a call for proposals will belaunched in 2015. Finally, the fundamental axis saw the creation of atransversal cancer axis at the University, complementary to BRIO activities andfocusing on technologies and fundamental research. In parallel, BRIO also startedits communication activities and 14 events were organised or supported in 2014to facilitate interactions between scientists, develop new partnerships andcreate a cancer research community in Bordeaux.


Cette présentation a été donnée dans le cadre du ScientificBRIO Day 2 organisé annuellement par le SIRIC BRIO et qui a pour but de réunirtous les acteurs du SIRIC BRIO et plus largement de la cancérologie à Bordeaux.

 



Intervention
Thème
Disciplines :

Dans la même collection

  • BRIO support to scientists
    Conférence
    00:13:28
    Favoris

    BRIO support to scientists

    Dessis
    Damien

    BRIO management team was voluntarily built upon various competencies from different horizons (industry, charity…) to provide a broad skillset which aims at supporting the Bordeaux cancer research

    • document 1 document 2 document 3
    • niveau 1 niveau 2 niveau 3
  • Innovation reimbursement
    Conférence
    00:09:10
    Favoris

    Innovation reimbursement

    Fillatreau
    Christian

    Interface technology/clinical/SHS/public health : case study interventional radiology Novel diagnostic and therapeutic strategies is a continuum of 3 strongly associated phases : clinical

    • document 1 document 2 document 3
    • niveau 1 niveau 2 niveau 3
  • Multisarc
    Conférence
    00:13:08
    Favoris

    Multisarc

    Italiano
    Antoine

    Translational science : how to move from biology to clinical applications Soft-tissues sarcomas represent an heterogeneous group of tumors. Stadard of care is surgical resection followed by

    • document 1 document 2 document 3
    • niveau 1 niveau 2 niveau 3
  • Curing leukemia ?
    Conférence
    00:19:52
    Favoris

    Curing leukemia ?

    Mahon
    François-Xavier

    Non-pharmaceutical medical innovations and public health The use of tyrosine kinase inhibitors (TKIs) targeted against the BCR-ABL1 oncoprotein has proven remarkably successful in chronic myeloid

    • document 1 document 2 document 3
    • niveau 1 niveau 2 niveau 3
  • Bordeaux Cancer Initiative
    Conférence
    00:16:54
    Favoris

    Bordeaux Cancer Initiative

    Dessis
    Damien
    Elustondo
    Frédéric

    Translational science : how to move from biology to clinical applications Upon request of the University, the SIRIC was mandated to develop a transversal cancer axis at the University. The axis

    • document 1 document 2 document 3
    • niveau 1 niveau 2 niveau 3
  • Standardizing G8 evaluation
    Conférence
    00:15:00
    Favoris

    Standardizing G8 evaluation

    Soubeyran
    Pierre

    Non-pharmaceutical innovations and public health Management of the frail elderly with cancer is a challenge. Beside a poor outcome as compared to younger subjects, physicians will face increased

    • document 1 document 2 document 3
    • niveau 1 niveau 2 niveau 3
Voir tout

Avec les mêmes intervenants et intervenantes

Sur le même thème